At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Application of Autologous Amniotic Fluiddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Collection and Application of Autologous Amniotic Fluid At Cesarean Delivery Closure - a Feasibility Study.
In Brief
A clinical study evaluating Application of Autologous Amniotic Fluid for Pregnancy Related and 2 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the feasibility of collecting amniotic fluid at delivery that will be immediately processed and then applied as a spray to the various layers of cesarean wound closure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsDuke University
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedApr 2020
Enrollment StartOct 2020
Primary CompletionSep 2023
Study CompletionSep 2024
TodayJul 2026
First PostedApr 24, 2020
Enrollment StartOct 1, 2020
Primary CompletionSep 1, 2023
Study CompletionSep 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 6.2 years ago
Interventions
Application of Autologous Amniotic Fluiddevice
Collection and reapplication of amniotic fluid at wound layers during a cesarean section.